Navigation Links
MJS™ Posterior Stabilized Knee System

ProductsMJS™ Posterior Stabilized Knee System
Company Encore Medical Corporation
Item MJS™ Posterior Stabilized Knee System
Features 
  • Precision ground to provide uniform contact zones throughout the range of motion.
  • Designed with a congruent distal radius to optimize contact areas and reduce contact stress.
  • Unique anterior notch located at the condylar gap prior to the patella bearing surface.
  • Can be used both with a standard MJS™ tibial Baseplate as well as with the Total Condylar Tibial Baseplate.
  • Conserves bone stock due to small notch cut in distal femur.
  • A Larger, more congruent surface area distributes forces equally, minimizing wear and therefore decreasing the chance of osteolysis.
    • Description MJS™ Posterior Stabilized knee system was designed to enhance durability, minimize polyethylene wear between all articulating surfaces and to minimize contact stress associated with wear in order to achieve a well balanced knee with normalized quadriceps and patellar tendon tension.
    Info Encore Medical Corporation
    Customer Service: (800) 456-8696
    Web site: http://www.encoremed.com/

    Related medicine products :

    1. MJS™ Anatomic Knee System
    2. Holladay Posterior Capsule Polisher and Curette
    3. Posterior Capsule Polisher, 23 g
    4. Posterior Capsule Polisher, 21 g
    5. Simcoe Posterior Chamber Lens Forceps
    6. Spine-Tract Posterior Lumbar Retractor System
    7. Image-Trac Posterior Spine Retractor System
    8. Graftech Posterior Ramp
    9. Tangent Posterior Impacted Instrument Set
    10. TANGENT Posterior Impacted Instrument Set
    11. PLIG (Posterior Lumbar Interbody Graft) Instruments
    Breaking Medicine News(10 mins):Health News:You Never Get a Second Chance to Make a First Impression: High-Definition for the Web 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 2Health News:Moravia Worldwide to Present Live Webinar on Creation and Use of Terminology in Localization 3Health News:Lung Cancer Alliance Praises Growing National Coalition 2Health News:Lung Cancer Alliance Praises Growing National Coalition 3Health News:Book Offers Help for Parents Struggling with Difficult Teens During the Upcoming Holidays 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4
    Breaking Medicine Technology:RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 2RecoverCare Announces the Relocation of Corporate Headquarters to Louisville 3AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Marc Russo Named Vice President of Senior Markets at Blue Shield of California 57132 1Marc Russo Named Vice President of Senior Markets at Blue Shield of California 57132 2MUSC Researchers Concerned About Online Drug Availability 57128 1MUSC Researchers Concerned About Online Drug Availability 57128 2HealthSouth Declares Dividend on 6 5 25 Series A Convertible Perpetual Preferred Stock 57123 1